» Articles » PMID: 34076598

The Impact of Oncogenic Mutations of the Viral Src Kinase on the Structure and Stability of the SH3 Domain

Overview
Specialty Biochemistry
Date 2021 Jun 2
PMID 34076598
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Src kinase belongs to the family of Src-related nonreceptor tyrosine kinases. Because of its physiological role in cell growth and proliferation, its activity is strictly controlled by several mechanisms. Nevertheless, in viral Src kinase (v-Src) some of these mechanisms fail, and its uncontrolled activity is responsible for the occurrence of cancer. Here, the crystal structures of three SH3-domain mutants of v-Src were determined to unveil the effects of these oncogenic mutations in this regulatory domain. Mutations in the n-Src and distal loops have a low impact on the overall structure of the domain and its capacity to form intertwined dimers. However, mutations in the RT loop compromise the stability of the domain and make the protein very prone to aggregation. Additionally, these mutations prevent the formation of intertwined dimers. The results show a synergistic effect between mutations in the RT loop and those in the n-Src and distal loops. Analysis of the structures of the v-Src SH3-domain mutants and the closed inactive conformation of cellular Src kinase (c-Src) point to a loss of the interactions that are required to establish the compact inactive form of the kinase. Nevertheless, an analysis of structures of the c-Src SH3 domain complexed with class I and II peptides points to minor changes in the interactions between the v-Src SH3 domain and these peptides. In this way, the structures reported here indicate that mutations in the RT loop might impair the kinase regulation mechanism without affecting the recognition of short proline-rich motifs in the target proteins of the kinase, thus explaining the oncogenic behaviour of the protein.

Citing Articles

Role of c-Src in Carcinogenesis and Drug Resistance.

Raji L, Tetteh A, Amin A Cancers (Basel). 2024; 16(1).

PMID: 38201459 PMC: 10778207. DOI: 10.3390/cancers16010032.


Heat Shock Protein 90 (HSP90) Inhibitors as Anticancer Medicines: A Review on the Computer-Aided Drug Discovery Approaches over the Past Five Years.

Magwenyane A, Ugbaja S, Amoako D, Somboro A, Khan R, Kumalo H Comput Math Methods Med. 2022; 2022:2147763.

PMID: 35685897 PMC: 9173959. DOI: 10.1155/2022/2147763.

References
1.
Sen B, Johnson F . Regulation of SRC family kinases in human cancers. J Signal Transduct. 2011; 2011:865819. PMC: 3135246. DOI: 10.1155/2011/865819. View

2.
Engen J, Wales T, Hochrein J, Meyn 3rd M, Ozkan S, Bahar I . Structure and dynamic regulation of Src-family kinases. Cell Mol Life Sci. 2008; 65(19):3058-73. PMC: 9357288. DOI: 10.1007/s00018-008-8122-2. View

3.
Trevino S, Schaefer S, Scholtz J, Pace C . Increasing protein conformational stability by optimizing beta-turn sequence. J Mol Biol. 2007; 373(1):211-8. PMC: 2084202. DOI: 10.1016/j.jmb.2007.07.061. View

4.
Pellegrini E, Piano D, Bowler M . Direct cryocooling of naked crystals: are cryoprotection agents always necessary?. Acta Crystallogr D Biol Crystallogr. 2011; 67(Pt 10):902-6. DOI: 10.1107/S0907444911031210. View

5.
Emsley P, Lohkamp B, Scott W, Cowtan K . Features and development of Coot. Acta Crystallogr D Biol Crystallogr. 2010; 66(Pt 4):486-501. PMC: 2852313. DOI: 10.1107/S0907444910007493. View